Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Galapagos NV
  6. News
  7. Summary
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Flat To Lower Pre-Bell Thursday

07/15/2021 | 09:14am EDT


© MT Newswires 2021
All news about GALAPAGOS NV
09/17GALAPAGOS : N.v., - galapagos announces positive chmp opinion for jyseleca® (fil..
PU
09/17GALAPAGOS : Gets European Medicines Agency's Positive Opinion on Ulcerative Coli..
MT
09/17GALAPAGOS : Says it Received European Medicines Agency Positive Opinion for Ulce..
MT
09/17GALAPAGOS : Announces positive chmp opinion for jyseleca® (filgotinib) for the t..
AQ
09/01GALAPAGOS NV : - Bionity - Galapagos announces planned retirement of CEO
AQ
08/31GALAPAGOS : announces planned retirement of CEO (Form 6-K)
PU
08/31Galapagos NV Announces Retirement of CEO Onno Van De Stolpe
CI
08/30ADRs Close Mostly Higher; Alibaba, Shell Trade Actively
DJ
08/30GALAPAGOS : CEO To Retire
MT
08/30GALAPAGOS : announces planned retirement of CEO
AQ
More news
Analyst Recommendations on GALAPAGOS NV
More recommendations
Financials
Sales 2021 519 M 609 M 609 M
Net income 2021 -224 M -263 M -263 M
Net cash 2021 3 243 M 3 802 M 3 802 M
P/E ratio 2021 -15,5x
Yield 2021 -
Capitalization 3 092 M 3 630 M 3 625 M
EV / Sales 2021 -0,29x
EV / Sales 2022 -0,17x
Nbr of Employees 1 397
Free-Float 73,8%
Chart GALAPAGOS NV
Duration : Period :
Galapagos NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GALAPAGOS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 47,19 €
Average target price 59,71 €
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Onno van de Stolpe Chief Executive Officer
Bart Filius President & Chief Operating Officer
Raj B. Parekh Chairman
Piet Wigerinck Chief Scientific Officer
Walid Abi-Saab Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GALAPAGOS NV-41.36%3 630
MODERNA, INC.311.65%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.07%49 407
CELLTRION, INC.-23.26%31 021
SEAGEN INC.-10.81%27 940